Ototoxicity Risk Assessment

Ototoxicity risk assessment evaluates pharmaceutical potential causing hearing loss or vestibular dysfunction. Aminoglycosides commonly cause permanent hearing loss. Cisplatin causes dose-dependent ototoxicity. Baseline audiometry establishes hearing status. Serial audiometry detects early ototoxic changes.

Risk factors including renal impairment increase ototoxicity severity. Preventive strategies including dose limitation reduce risk. Clinical monitoring detects hearing loss progression. Regulatory submissions address ototoxicity risks. Patient counselling emphasises hearing protection.